| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-inflammatory agents and renal function
|
Brater, D.Craig
|
|
2002
|
|
3S |
p. 33-42
10 p.
|
artikel
|
| 2 |
Are there new targets for juvenile idiopathic arthritis?
|
Martini, Alberto
|
|
|
|
3S |
p. S11-S13
|
artikel
|
| 3 |
Artificial intelligence in detecting early RA
|
Stoel, Berend C.
|
|
|
|
3S |
p. S25-S28
|
artikel
|
| 4 |
Challenges in systemic sclerosis trial design
|
Denton, Christopher P.
|
|
|
|
3S |
p. S3-S7
|
artikel
|
| 5 |
Challenges of managing chronic pain in the elderly
|
Ruoff, Gary E.
|
|
2002
|
|
3S |
p. 43-50
8 p.
|
artikel
|
| 6 |
CME Post-Test
|
|
|
2002
|
|
3S |
p. 51-54
4 p.
|
artikel
|
| 7 |
Coxibs: Evolving role in pain management
|
Katz, Nathaniel
|
|
2002
|
|
3S |
p. 15-24
10 p.
|
artikel
|
| 8 |
Current perspectives on fertility, pregnancy and childbirth in patients with Rheumatoid Arthritis
|
Smeele, H.T.W.
|
|
|
|
3S |
p. S32-S35
|
artikel
|
| 9 |
Current understanding of gout and optimal management strategies
|
So, Alexander
|
|
|
|
3S |
p. S1
|
artikel
|
| 10 |
Do we need new trial designs in spondyloarthritis?
|
Landewé, Robert B.M.
|
|
|
|
3S |
p. S8-S10
|
artikel
|
| 11 |
Editorial Board
|
|
|
2002
|
|
3S |
p. A1-
1 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
|
3S |
p. ii
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
|
3S |
p. ii
|
artikel
|
| 14 |
EULAR/ACR classification criteria for SLE
|
Aringer, Martin
|
|
|
|
3S |
p. S14-S17
|
artikel
|
| 15 |
Gout epidemiology and comorbidities
|
Singh, Jasvinder A.
|
|
|
|
3S |
p. S11-S16
|
artikel
|
| 16 |
Introduction
|
Hochberg, Marc C.
|
|
2002
|
|
3S |
p. 1-3
3 p.
|
artikel
|
| 17 |
Linking of genetic risk variants to disease-specific gene expression via multi-omics studies in rheumatoid arthritis
|
Suzuki, Akari
|
|
|
|
3S |
p. S49-S53
|
artikel
|
| 18 |
Mechanoflammation in osteoarthritis pathogenesis
|
Vincent, Tonia L.
|
|
|
|
3S |
p. S36-S38
|
artikel
|
| 19 |
Modulation of bioavailability of proinflammatory cytokines produced by myeloid cells
|
Nosenko, Maxim A.
|
|
|
|
3S |
p. S39-S42
|
artikel
|
| 20 |
New directions in anti-inflammatory therapy and pain management a CME-certified journal supplement
|
|
|
2002
|
|
3S |
p. i-iii
nvt p.
|
artikel
|
| 21 |
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis
|
Hochberg, Marc C.
|
|
2002
|
|
3S |
p. 4-14
11 p.
|
artikel
|
| 22 |
Pegloticase treatment of chronic refractory gout: Update on efficacy and safety
|
Schlesinger, Naomi
|
|
|
|
3S |
p. S31-S38
|
artikel
|
| 23 |
Preface
|
Breedveld, F.C.
|
|
|
|
3S |
p. S1-S2
|
artikel
|
| 24 |
Real world data in rheumatology
|
Hyrich, Kimme L.
|
|
|
|
3S |
p. S22-S24
|
artikel
|
| 25 |
Table of Contents
|
|
|
|
|
3S |
p. A1
|
artikel
|
| 26 |
The biology of urate
|
Keenan, Robert T.
|
|
|
|
3S |
p. S2-S10
|
artikel
|
| 27 |
The eye in spondyloarthritis✰
|
Rosenbaum, James T.
|
|
|
|
3S |
p. S29-S31
|
artikel
|
| 28 |
The gastrointestinal effects of nonselective NSAIDs and COX-2–selective inhibitors
|
Laine, Loren
|
|
2002
|
|
3S |
p. 25-32
8 p.
|
artikel
|
| 29 |
The neurobiological underpinnings of placebo and nocebo effects
|
Benedetti, Fabrizio
|
|
|
|
3S |
p. S18-S21
|
artikel
|
| 30 |
Therapeutic approaches in the treatment of gout
|
Pillinger, Michael H.
|
|
|
|
3S |
p. S24-S30
|
artikel
|
| 31 |
Unravelling the mysteries of gout by multimodality imaging
|
Abdellatif, Waleed
|
|
|
|
3S |
p. S17-S23
|
artikel
|
| 32 |
Updates on NET formation in health and disease
|
Leppkes, Moritz
|
|
|
|
3S |
p. S43-S48
|
artikel
|
Tijdschrift beschrijving